ClinicalTrials.Veeva

Menu

Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)

K

Kenneth Peters, MD

Status

Completed

Conditions

Interstitial Cystitis

Study type

Observational

Funder types

Other

Identifiers

NCT00704457
2004-024

Details and patient eligibility

About

Urine will be collected and sent to the University of Maryland. Urines will be analyzed for urine markers.

Full description

Urine will be collected and flash frozen in liquid nitrogen then placed in a -70 C freezer. All urine will be collected and stored until the final follow-up is complete. The urine samples will then be sent as a single batch to the Department of Infectious Disease, University of Maryland. Urines will be assayed in a blinded fashion and a written report of the levels of each of the 3 urine markers will be sent to Beaumont Hospital. Change in urine marker levels will be analyzed and correlated with change in symptom scores.

Enrollment

11 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients will be drawn from Dr. Peters patient base that covers Southeast Michigan.

Exclusion criteria

  • Male

Trial design

11 participants in 1 patient group

A
Description:
One arm study. Urine collection.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems